Jason Ryan

This profile gathers the share dealings of Jason Ryan across 2 companies, led by Foundation Medicine, Inc. and GeneDx Holdings Corp. In total, 77 filings cover trades dated from 1 April 2016 to 18 June 2026.

On the open market, the record shows 2 purchases worth €149k and 51 sales worth €14.6M. Sales outweigh purchases by €14.5M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 3 share grants and 17 option exercises.

On 23 June 2026 came the latest disclosure, an option exercise in GeneDx Holdings Corp. The latest purchase dates back some time: it was published 1,068 days ago, on 20 November 2023. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.